3/25/2025 | HYLM | Novolex sees early tenders for $175.8 million 7.95% debentures
|
4/1/2022 | HY | Market Commentary: Morning Commentary: Junk bonds unchanged post nonfarm payrolls; cash inflows continue
|
3/31/2022 | HY | Market Commentary: Morning Commentary: Wednesday deals trade up; funds eye first weekly inflows in 11 weeks
|
3/30/2022 | HY | Market Commentary: Junk bond issuance resumes; Yum! holds; Wesco jumps on recapitalization, LABL down
|
3/30/2022 | GNHY | New Issue: Clydesdale Acquisition/Novolex prices downsized $1.61 billion notes in two tranches
|
3/30/2022 | CLHY | Market Commentary: Novolex term loan frees to trade atop OID; Solenis accelerates commitment deadline
|
3/30/2022 | GNHY | Clydesdale Acquisition/Novolex cuts notes offering to $1.61 billion, upsizes term loan
|
3/29/2022 | HY | Market Commentary: Junk secondary rallies on cease-fire optimism; EQT upgraded; Nielson jumps on buyout
|
3/29/2022 | HY | Market Commentary: Morning Commentary: Junk bond prices improve amid renewed risk appetite; calendar eyed
|
3/28/2022 | HY | Market Commentary: Presidio adds-on; Novolex on deck; Plantronics spikes on buyout; YUM! improves; Occidental active
|
3/28/2022 | GNHY | Novolex/Clydesdale starts roadshow for $1.98 billion sustainability-linked notes offering
|
3/25/2022 | HY | Market Commentary: Yum! below par; junk secondary soft amid Treasury rout; Ford weakens; Owens & Minor holds
|
3/25/2022 | HY | Market Commentary: Yum! below par; junk secondary soft amid Treasury rout; Ford weakens; Owens & Minor holds
|
3/24/2022 | HY | Market Commentary: Yum! doubles; Novolex on deck; Ford at a premium; Owens & Minor gains; funds lose $2.7 billion
|
3/24/2022 | HY | Market Commentary: Yum! doubles; Novolex on deck; Ford at a premium; Owens & Minor gains; funds lose $2.7 billion
|
3/24/2022 | HY | Novolex expected to bring $1.98 billion in secured and unsecured notes March 28 week
|
3/24/2022 | HY | Novolex expected to bring secured and unsecured notes next week backing Apollo buyout
|
3/21/2022 | CLHY | Market Commentary: Forefront Dermatology tweaks loan commitment deadline; Novolex comes to market
|
2/24/2021 | CLHY | Market Commentary: Franchise, DRW Holdings, Wedgewood, DiversiTech, Science, Novolex, Infinite, Hillman break
|
2/23/2021 | CLHY | Market Commentary: BellRing, Sophos, Schweitzer, BrightSpring, SCP break; Peraton, Infinite and more revised
|
2/16/2021 | CLHY | Market Commentary: DigiCert, Victory Capital, Blackstone break; RealPage, Liftoff, Ivanti accelerate deadlines
|